Market revenue in 2023 | USD 4.0 thousand |
Market revenue in 2030 | USD 5.6 thousand |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Igra testing |
Fastest growing segment | IGRA Testing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD thousand |
Market segmentation | IGRA Testing |
Key market players worldwide | Diasorin SpA, BioMerieux SA, Oxford Immunotec, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, T2 Biosystems Inc, IGeneX, Gold Standard Diagnostics, Zeus Scientific, Inc., Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lyme disease testing market will help companies and investors design strategic landscapes.
Igra testing was the largest segment with a revenue share of 22.5% in 2023. Horizon Databook has segmented the Norway lyme disease testing market based on igra testing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway lyme disease testing market , including forecasts for subscribers. This country databook contains high-level insights into Norway lyme disease testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account